Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service
dc.contributor.author | Maher, Eamonn R. | |
dc.contributor.author | Adlard, Julian | |
dc.contributor.author | Barwell, Julian | |
dc.contributor.author | Brady, Angela F. | |
dc.contributor.author | Brennan, Paul | |
dc.contributor.author | Cook, Jackie | |
dc.contributor.author | Crawford, Gillian S. | |
dc.contributor.author | Dabir, Tabib | |
dc.contributor.author | Davidson, Rosemarie | |
dc.contributor.author | Dyer, Rebecca | |
dc.contributor.author | Harrison, Rachel | |
dc.contributor.author | Forde, Claire | |
dc.contributor.author | Halliday, Dorothy | |
dc.contributor.author | Hanson, Helen | |
dc.contributor.author | Hay, Eleanor | |
dc.contributor.author | Higgs, Jenny | |
dc.contributor.author | Jones, Mari | |
dc.contributor.author | Lalloo, Fiona | |
dc.contributor.author | Miedzybrodzka, Zosia | |
dc.contributor.author | Ong, Kai Ren | |
dc.contributor.author | Pelz, Frauke | |
dc.contributor.author | Ruddy, Deborah | |
dc.contributor.author | Snape, Katie | |
dc.contributor.author | Whitworth, James | |
dc.contributor.author | Sandford, Richard N. | |
dc.date.accessioned | 2024-02-07T08:19:01Z | |
dc.date.available | 2024-02-07T08:19:01Z | |
dc.date.issued | 2022-05-18 | |
dc.identifier | 214987313 | |
dc.identifier | 9d0bb60e-8223-437e-95a8-aed0983fef9e | |
dc.identifier | 000757918300002 | |
dc.identifier | 85124725159 | |
dc.identifier.citation | Maher , E R , Adlard , J , Barwell , J , Brady , A F , Brennan , P , Cook , J , Crawford , G S , Dabir , T , Davidson , R , Dyer , R , Harrison , R , Forde , C , Halliday , D , Hanson , H , Hay , E , Higgs , J , Jones , M , Lalloo , F , Miedzybrodzka , Z , Ong , K R , Pelz , F , Ruddy , D , Snape , K , Whitworth , J & Sandford , R N 2022 , ' Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service ' , British Journal of Cancer , vol. 126 , pp. 1339–1345 . https://doi.org/10.1038/s41416-022-01724-7 | en |
dc.identifier.issn | 0007-0920 | |
dc.identifier.uri | http://aura-test.abdn.ac.uk/handle/2164/20107 | |
dc.description | Acknowledgements We acknowledge support from the NIHR UK Rare Genetic Disease Research Consortium. We also thank the many individuals who contributed to VHL clinical services in Leicester (Corrina Powell, Vanita Jivanji and Mark C Dalby), Manchester (Zerin Hyder, Ruth Heaton), North West Thames Regional Genetics Service (Lauren Limb), Wessex Clinical Genetics Service (Professor Diana Eccles), West Midlands Clinical Genetics Service (Sue Carless). We thank VHL Alliance UK fpatient support group or their help in designing the audit. Funding We thank the NIHR Cambridge Biomedical Research Centre and VHL Alliance UK for funding research into VHL disease. The University of Cambridge has received salary support (ERM, RNS) from the NHS in the East of England through the Clinical Academic Reserve. The views expressed are those of the authors and not necessarily those of the NHS or Department of Health. | en |
dc.format.extent | 7 | |
dc.format.extent | 669463 | |
dc.language.iso | eng | |
dc.relation.ispartof | British Journal of Cancer | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | GERMLINE MUTATIONS | en |
dc.subject | GENETIC REGISTER | en |
dc.subject | SUPPRESSOR GENE | en |
dc.subject | NATURAL-HISTORY | en |
dc.subject | HEMANGIOBLASTOMAS | en |
dc.subject | IDENTIFICATION | en |
dc.subject | MANAGEMENT | en |
dc.subject | FEATURES | en |
dc.subject | R Medicine (General) | en |
dc.subject | RC0254 Neoplasms. Tumors. Oncology (including Cancer) | en |
dc.subject | Supplementary Information | en |
dc.subject.lcc | R1 | en |
dc.subject.lcc | RC0254 | en |
dc.title | Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Centre for Health Data Science | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Medical Genetics Group | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | https://doi.org/10.1038/s41416-022-01724-7 | |
dc.identifier.vol | 126 | en |